» Articles » PMID: 39240883

The Time-dependent Changes in a Mouse Model of Traumatic Brain Injury with Motor Dysfunction

Overview
Journal PLoS One
Date 2024 Sep 6
PMID 39240883
Authors
Affiliations
Soon will be listed here.
Abstract

Traumatic brain injury (TBI) results from sudden accidents, leading to brain damage, subsequent organ dysfunction, and potentially death. Despite extensive studies on rodent TBI models, there is still high variability in terms of target points, and this results in significantly different symptoms between models. In this study, we established a more concise and effective TBI mouse model, which included locomotor dysfunctions with increased apoptosis, based on the controlled cortical impact method. Behavioral tests, such as elevated body swing, rotarod, and cylinder tests were performed to assess the validity of our model. To investigate the underlying mechanisms of injury, we analyzed the expression of proteins associated with immune response and the apoptosis signaling pathway via western blotting analysis and immunohistochemistry. Upon TBI induction, the mouse subjects showed motor dysfunctions and asymmetric behavioral assessment. The expression of Bax gradually increased over time and reached its maximum 3 days post-surgery, and then declined. The expression of Mcl-1 showed a similar trend to Bax. Furthermore, the expression of caspase-3, ROCK1, and p53 were highly elevated by 3 days post-surgery and then declined by 7 days post-surgery. Importantly, immunohistochemistry revealed an immediate increase in the level of Bcl-2 at the lesion site upon TBI induction. Also, we found that the expression of neuronal markers, such as NeuN and MAP2, decreased after the surgery. Interestingly, the increase in NFH level was in line with the symptoms of TBI in humans. Collectively, our study demonstrated that the established TBI model induces motor dysfunction, hemorrhaging, infarctions, and apoptosis, closely resembling TBI in humans. Therefore, we predict that our model may be useful for developing effective treatment option for TBI.

References
1.
Ramalingam M, Jeong H, Hwang J, Cho H, Kim B, Kim E . Autophagy Signaling by Neural-Induced Human Adipose Tissue-Derived Stem Cell-Conditioned Medium during Rotenone-Induced Toxicity in SH-SY5Y Cells. Int J Mol Sci. 2022; 23(8). PMC: 9031864. DOI: 10.3390/ijms23084193. View

2.
Endo F, Kasai A, Soto J, Yu X, Qu Z, Hashimoto H . Molecular basis of astrocyte diversity and morphology across the CNS in health and disease. Science. 2022; 378(6619):eadc9020. PMC: 9873482. DOI: 10.1126/science.adc9020. View

3.
Scarboro M, McQuillan K . Traumatic Brain Injury Update. AACN Adv Crit Care. 2021; 32(1):29-50. DOI: 10.4037/aacnacc2021331. View

4.
Ramalingam M, Jang S, Jeong H . Therapeutic Effects of Conditioned Medium of Neural Differentiated Human Bone Marrow-Derived Stem Cells on Rotenone-Induced Alpha-Synuclein Aggregation and Apoptosis. Stem Cells Int. 2021; 2021:6658271. PMC: 7847328. DOI: 10.1155/2021/6658271. View

5.
Nguyen R, Fiest K, McChesney J, Kwon C, Jette N, Frolkis A . The International Incidence of Traumatic Brain Injury: A Systematic Review and Meta-Analysis. Can J Neurol Sci. 2016; 43(6):774-785. DOI: 10.1017/cjn.2016.290. View